SCHEMBL6583644

SCHEMBL6583644

CC(C)(C)OC(=O)N1CCC(C2(NC(=O)Nc3cccc(C#N)c3)CCCCCC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.48
HSD17B10 Q99714 1/20 0.48
EPHX2 P34913 5/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
SIRT2 Q8IXJ6 1/20 0.45
SIRT1 Q96EB6 1/20 0.45
HIF1A Q16665 1/20 0.43
CYP1A2 P05177 3/20 0.43
USP2 O75604 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.42
USP30 Q70CQ3 1/20 0.42
GPR119 Q8TDV5 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7249158 0.84 TSHR (0.44) CYP2D6HSD17B10CYP3A4CYP2C9CYP2C19
SCHEMBL6582812 0.81 CA12 (0.56) CYP2D6HSD17B10EPHX2SIRT2SIRT1
SCHEMBL6582903 0.80 GRM5 (0.51) HSD17B10CYP3A4HIF1AALDH1A1TSHR
SCHEMBL17296358 0.79 BRD4 (0.57) CYP2D6HSD17B10USP30
SCHEMBL6584416 0.79 CCR3 (0.62) ALDH1A1
SCHEMBL6583982 0.78 CCR3 (0.64) ALDH1A1
SCHEMBL377671 0.77 ALDH1A1 (0.58) CYP2D6HSD17B10CYP3A4ALDH1A1GPR119
SCHEMBL6583612 0.77 CYP3A4 (0.44) CYP2D6CYP3A4CYP2C9CYP2C19HIF1A
Acetic Acid SCHEMBL29291810 0.77 KMT2A (0.52) CYP2D6HSD17B10SIRT2HIF1ACYP1A2
SCHEMBL6590015 0.76 CCR3 (0.48) CYP3A4HIF1ACYP1A2USP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0960104-B1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-06-16 EP disclosed
US-6521614-B1 Anticoagulant agents for treatment and prevention of thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-02-18 US disclosed
EP-0960104-A1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-12-01 EP disclosed
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed
WO-1997038984-A1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-23 WO disclosed